Stage I-IIa Cervical Cancer (FIGO 2009)
Conditions
Interventions
Sponsors
Cancer Hospital of Shantou University Medical College
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with FIGO 2009 stage I-IIa cervical cancer based on gynecological examination, imaging studies, and pathological biopsy. 2.Patients who have not received any radiotherapy or chemotherapy prior to surgery. 3.Patients with essentially complete clinicopathological data. 4.Patients who have completed auxiliary examinations (including complete blood count, coagulation function, liver function, and tumor markers) within one week before surgery. 5.Patients who demonstrated good compliance by cooperating with all treatment procedures.
Exclusion criteria
Exclusion criteria: 1.Patients with concomitant acute or chronic infections, hematological diseases, autoimmune diseases, organ dysfunction, cardiovascular accidents, diabetes, thrombotic diseases, or other conditions that may affect hematological parameters. 2.Patients who had used medications (e.g., hormonal drugs, non-steroidal anti-inflammatory drugs, antiplatelet drugs or received blood) or blood product transfusions that may affect complete blood count, coagulation function, or liver function tests prior to treatment. 3.Patients with cervical stump carcinoma, metastatic carcinoma, pregnancy, or cervical cancer incidentally discovered after radical trachelectomy or total hysterectomy. 4.Patients with other concurrent malignant or borderline tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease-Free Survival;Overall survival; | — |
Countries
China
Contacts
Public ContactLi Congzhu
Cancer Hospital of Shantou University Medical College
Outcome results
None listed